Amgen's $10B Onyx Buy Takes Training Wheels Off 251(h)
The $125-per-share deal struck Sunday takes advantage of 251(h), the new rule that allows buyers in tender offers to close as soon as they have a simple majority of shares, rather than claw their way to the 90 percent squeeze-out threshold.
Amgen is at least the third buyer to invoke...
Already a subscriber? Click here to login